The presentation will focus on the clinical use of PRAMA Implants, and its specific biological characteristics. PRAMA Implants have been on the market for over a decade, and the particular neck design has indicated that ABL (Annual Bone Loss) and Soft tissue stability and evaluation with the Pink Score are reliable and stable. Recent review articles have shown retrospective data up to six years, showing clinical stability and mostly, minimizing clinical challenges seen with conventional implant and restorative dentistry. The seminar will show some clinical cases, and the biological principles, based on current scientific knowledge.